1. Follicle-stimulating hormone or human menopausal gonadotropin for ovarian stimulation in in vitro fertilization cycles: a meta-analysis 
Rina Agrawal, M.D., Jeremy Holmes, Howard S Jacobs, M.D. 
Fertility and Sterility 
Volume 73, Issue 2, Pages (February 2000)
DOI: /S (99)

2. FIGURE 1
The confidence interval (95% confidence interval, 1.01–7.72) and odds ratio (OR = 2.80) of the clinical pregnancies per cycle of IVF in each of the studies and also the common odds ratio. Heterogeneity χ2 = 0.16 (df = 2), P=.924. Test of OR = 1: z = 1.99, P=.047.
Agrawal. Follicle-stimulating hormone. Fertil Steril 2000.
Fertility and Sterility  , DOI: ( /S (99) )

3. FIGURE 2
The confidence interval (95% confidence interval, 0.85–3.50) and odds ratio (OR = 1.72) of the clinical pregnancies per cycle of IVF in this study. Test of OR = 1: z = 1.50, P=.133.
Agrawal. Follicle-stimulating hormone. Fertil Steril 2000.
Fertility and Sterility  , DOI: ( /S (99) )

4. FIGURE 3
The confidence interval (95% confidence interval, 0.58–1.05) and odds ratio (OR = 0.77) of clinical pregnancies per cycle of IVF in each of the studies included in the meta-analysis and also the common odds ratio. Heterogeneity χ2 = (df = 11), P=.489. Test of OR = 1: z = 1.63, P=.076.
Agrawal. Follicle-stimulating hormone. Fertil Steril 2000.
Fertility and Sterility  , DOI: ( /S (99) )